Smoking Cessation for Smokers With Sleep Problems
2 other identifiers
interventional
19
1 country
1
Brief Summary
This is a pilot research study examining two types of behavioral counseling along with the nicotine patch for smoking cessation. The study is designed to find out whether one of these counseling interventions is more effective for smoking cessation among individuals with sleep problems. The study has three parts: 1) an intake session; 2) a 10-week treatment phase, and 3) a 1-month follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 13, 2011
CompletedFirst Posted
Study publicly available on registry
January 17, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedResults Posted
Study results publicly available
December 21, 2017
CompletedDecember 21, 2017
December 1, 2017
1.2 years
January 13, 2011
April 21, 2017
December 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Smoking Abstinence
Smoking abstinence is operationally defined as "no smoking on the last 7 days of the last week of treatment. And no smoking within the last 7 days at the first follow-up visit 4 weeks after completing treatment."
1 Week
Secondary Outcomes (2)
Self-Control to Resist Smoking Cues
4 Weeks
Sleep Efficiency
Change from Baseline at 4 weeks
Study Arms (2)
Cognitive-Behavioral Counseling
ACTIVE COMPARATORThe intervention consists of 8 sessions provided over 10 weeks. Counseling commences 4 weeks before quitting smoking. Participants will also receive the nicotine patch for 6 weeks starting on the day of quit date.
Smoking Cessation Counseling
PLACEBO COMPARATORThe intervention consists of 8 sessions provided over 10 weeks. Counseling commences 4 weeks before quitting smoking. Participants will also receive the nicotine patch for 6 weeks starting on the day of quit date.
Interventions
The cognitive-behavioral intervention integrates standard smoking counseling adapted from the American Lung Association Freedom from Smoking program along with cognitive-behavioral techniques for improving insomnia.
The smoking cessation counseling intervention will incorporate standard psychoeducational and behavioral smoking counseling techniques adapted from the American Lung Association Freedom from Smoking program.
Eligibility Criteria
You may qualify if:
- Between the ages of 18 and 75.
- Smoking 10 or more cigarettes per day for at least 1 year.
- An expired air breath carbon monoxide level \> 10 ppm.
- Motivated to stop smoking.
- Understand English.
- Meet DSM-IV criteria for insomnia.
- Report sleep latency or waking after sleep onset \>30 minutes on ≥6 occasions within past month.
You may not qualify if:
- History of allergic reactions to adhesives.
- Unstable psychiatric/medical conditions such as current suicidal or homicidal ideation, acute psychosis, dementia.
- Have a current diagnosis of DSM-IV alcohol or drug dependence other than nicotine.
- Use of tobacco products other than cigarettes or use of marijuana.
- Intention to use nicotine replacement therapy, varenicline, or bupropion during study participation.
- Females of childbearing potential who are pregnant, nursing, or not practicing effective contraception (oral, injectable, or implantable contraceptives, intrauterine device, or barrier method with spermicide).
- New onset of psychiatric disorders or new psychotropic medications within the past 3 months.
- Inability to read/understand English.
- History of sleep apnea based on responses to Berlin Questionnaire.
- History of restless leg syndrome.
- Current night or rotating shift work.
- Proposed travel across 2 or more time zones during study participation.
- Medical/psychiatric conditions contraindicated for sleep restriction (i.e., seizure disorders, severe excessive daytime sleepiness - Epworth Scale \>18, and bipolar disorder).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Yale University School of Medicine
New Haven, Connecticut, 06511, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Lisa Fucito, PhD
- Organization
- Yale University School of Medicine
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Fucito, PhD
Yale University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2011
First Posted
January 17, 2011
Study Start
December 1, 2010
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
December 21, 2017
Results First Posted
December 21, 2017
Record last verified: 2017-12